Project Details
Description
A Phase 3 Global, Double-Blind, Randomized, Placebo???Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin???Mediated Amyloid Cardiomyopathy (ATTR CM)
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/21 → 6/30/24 |
Funding
- IONIS PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.